Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» acute myeloid leukemia
acute myeloid leukemia
FDA grants priority review for Daiichi Sankyo’s AML medicine
Pharmaceutical Business Review
Tue, 10/25/22 - 10:37 am
FDA
priority review
Daiichi Sankyo
quizartinib
acute myeloid leukemia
BlueSphere Bio's Newly Minted CEO Calls for Urgency on Day One
BioSpace
Wed, 10/5/22 - 10:40 am
BlueSphere Bio
Pharma CEOs
Keir Loiacono
acute myeloid leukemia
EHA: Survival data sets Daiichi Sankyo’s quizartinib back on track
Pharmaforum
Mon, 06/13/22 - 10:44 am
Daiichi Sankyo
EHA
quizartinib
clinical trials
acute myeloid leukemia
Gilead’s CD47 trials freed of FDA hold—for the most part
Fierce Biotech
Mon, 04/11/22 - 07:23 pm
Gilead Sciences
clinical trials
CD47
magrolimab
acute myeloid leukemia
FDA
FDA puts Curis' leukemia trial on partial hold after patient death spurs review of muscle breakdown
Fierce Biotech
Mon, 04/4/22 - 10:35 am
Curis
FDA
clinical trials
patient deaths
emavusertib
acute myeloid leukemia
Bristol Myers Squibb's Idhifa Flunks Acute Myeloid Leukemia Trial
BioSpace
Tue, 08/25/20 - 11:14 am
Bristol-Myers Squibb
clinical trials
enasidenib
acute myeloid leukemia
ASCO data for Amgen’s acute leukemia drug disappoint, but path forward remains, experts say
MedCity News
Mon, 06/1/20 - 11:45 pm
ASCO 2020
Amgen
AMG 330
acute myeloid leukemia
FDA accepts for priority review Bristol Myers Squibb’s application for CC-486 for maintenance treatment of adults in remission with AML
Pharmaceutical Business Review
Mon, 05/4/20 - 10:36 am
Bristol-Meyers Squibb
FDA
CC-486
AML
acute myeloid leukemia
Roche and Celgene set for battle in acute myelogenous leukaemia
EP Vantage
Wed, 09/18/19 - 09:54 am
Celgene
Roche
AML
acute myeloid leukemia
CC-486
Venclexta
Celgene's AML drug clears late-stage test
Endpoints
Mon, 09/16/19 - 09:17 am
Celgene
AML
CC-486
acute myeloid leukemia
Celgene's phase 3 AML test chalks up a win
Fierce Biotech
Fri, 09/13/19 - 10:52 am
Celgene
acute myeloid leukemia
CC-486
clinical trials
FDA declines to approve Daiichi Sankyo's blood cancer treatment
Reuters
Fri, 06/21/19 - 11:55 pm
Daiichi Sankyo
FDA
quizartinib
acute myeloid leukemia
BerGenBio posts updated data on trial of elderly AML patients
Fierce Biotech
Fri, 06/14/19 - 10:12 am
BerGenBio
bemcentinib
AML
acute myeloid leukemia
Daiichi Sankyo Takes Two Products to FDA Advisory Panel; Gets One Yes, One No
BioSpace
Wed, 05/15/19 - 11:42 am
Daiichi Sankyo
FDA
quizartinib
acute myeloid leukemia
pexidartinib
TGCT
FDA questions credibility of Daiichi data ahead of AdComm
Fierce Biotech
Mon, 05/13/19 - 09:32 am
FDA
Daiichi Sankyo
quizartinib
acute myeloid leukemia
AACR: Astellas pads Xospata's AML lead with chemo-beating survival data
Fierce Pharma
Mon, 04/1/19 - 12:38 pm
Astellas
Xospata
acute myeloid leukemia
AML
AACR
Deaths spur partial hold for Xencor’s CD3 bispecific for leukemia, partnered with Novartis in $2.5B deal
Endpoints
Wed, 02/20/19 - 10:00 am
Xencor
XmAb14045
bispecific antibodies
acute myeloid leukemia
Playing a hot hand in cancer R&D, Pfizer scores its 4th drug approval in just 2 months
Endpoints
Sat, 11/24/18 - 01:30 pm
Pfizer
FDA
glasdegib
acute myeloid leukemia
AML
FDA Approves Roche Subsidiary's Treatment for Acute Myeloid Leukemia
Yahoo/Guru Focus
Sat, 11/24/18 - 01:27 pm
Roche
Genentech
Venclexta
FDA
AML
acute myeloid leukemia
MaaT Pharma Releases Results Of Microbiome Restoration Therapy in Acute Myeloid Leukemia Patients
CP Wire
Fri, 11/2/18 - 09:38 am
MaaT Pharma
acute myeloid leukemia
microbiome
Pages
1
2
3
4
5
next ›
last »